BDBM309994 US9657003, Bicalutamide
CHEMBL63560 US11648234, Compound R-Bicalutamide BDBM18678 US20230382870, (R) Bicalutumide (R)-Bicalutamide US11230523, Compound R-Bicalutamide US10806720, Compound R-Bicalutamide (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorobenzene)sulfonyl]-2-hydroxy-2-methylpropanamide
CHEMBL409 US9682960, CAS BDBM18525 N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorobenzene)sulfonyl]-2-hydroxy-2-methylpropanamide US9126941, Bicalutamide Bicalutamide US20230382870, Bicalutumide US11046713, Example Bicalutamide
(2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorobenzene)sulfonyl]-2-hydroxy-2-methylpropanamide (S)-Bicalutamide BDBM18692 CHEMBL124881
(2R)-3-[(3-aminophenyl)sulfanyl]-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide Bicalutamide Analogue, (R)-6 BDBM18680
(2S)-3-[(3-aminophenyl)sulfanyl]-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide Bicalutamide Analogue, (S)-6 BDBM18694
(2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-[(3-isothiocyanatophenyl)sulfanyl]-2-methylpropanamide Bicalutamide Analogue, (S)-8 BDBM18696
Bicalutamide Analogue, (R)-10 (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-[(3-isothiocyanatobenzene)sulfonyl]-2-methylpropanamide BDBM18684
Bicalutamide Analogue, (R)-5 BDBM18679 (2R)-3-[(4-aminophenyl)sulfanyl]-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
Bicalutamide Analogue, (R)-8 (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-[(3-isothiocyanatophenyl)sulfanyl]-2-methylpropanamide BDBM18682
Bicalutamide Analogue, (S)-5 (2S)-3-[(4-aminophenyl)sulfanyl]-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide BDBM18693
(2R)-3-{[3-(2-chloroacetamido)phenyl]sulfanyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide BDBM18686 Bicalutamide Analogue, (R)-12
(2R)-3-{[4-(2-bromoacetamido)benzene]sulfonyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide BDBM18691 Bicalutamide Analogue, (R)-17
BDBM18687 Bicalutamide Analogue, (R)-13 (2R)-3-{[4-(2-bromoacetamido)phenyl]sulfanyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
BDBM18689 Bicalutamide Analogue, (R)-15 (2R)-3-{[4-(2-chloroacetamido)benzene]sulfonyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
BDBM18697 Bicalutamide Analogue, (S)-11 (2S)-3-{[4-(2-chloroacetamido)phenyl]sulfanyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
Bicalutamide Analogue, (R)-14 BDBM18688 (2R)-3-{[3-(2-bromoacetamido)phenyl]sulfanyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
Bicalutamide Analogue, (R)-16 BDBM18690 (2R)-3-{[3-(2-chloroacetamido)benzene]sulfonyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
Bicalutamide Analogue, (R)-11 CHEMBL333745 (2R)-3-{[4-(2-chloroacetamido)phenyl]sulfanyl}-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide BDBM18685
(2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-[(4-isothiocyanatobenzene)sulfonyl]-2-methylpropanamide Bicalutamide Analogue, (R)-9 BDBM18683 BMC146525 arylisothiocyanato derivative, R-37
BMC146525 arylisothiocyanato derivative, R-35 (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-[(4-isothiocyanatophenyl)sulfanyl]-2-methylpropanamide Bicalutamide Analogue, (R)-7 BDBM18681
BMC146525 arylisothiocyanato derivative, S-35 Bicalutamide Analogue, (S)-7 (2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-[(4-isothiocyanatophenyl)sulfanyl]-2-methylpropanamide BDBM18695
- Pertusati, F; Ferla, S; Bassetto, M; Brancale, A; Khandil, S; Westwell, AD; McGuigan, C A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF Eur J Med Chem 180: 1-14 (2019)
- Bassetto, M; Ferla, S; Pertusati, F; Kandil, S; Westwell, AD; Brancale, A; McGuigan, C Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer. Eur J Med Chem 118: 230-43 (2016)
- Kirkovsky, L; Mukherjee, A; Yin, D; Dalton, JT; Miller, DD Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring. J Med Chem 43: 581-90 (2000)
- Parent, EE; Dence, CS; Jenks, C; Sharp, TL; Welch, MJ; Katzenellenbogen, JA Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging. J Med Chem 50: 1028-40 (2007)